推进 HCM 医疗管理的极限 : 当前药物治疗方案的回顾。
关键词: drug trials hypertrophic cardiomyopathy mavacamten myosin inhibitors pharmacotherapy
Mesh : Angiotensin II Type 1 Receptor Blockers / therapeutic use Animals Calcium Channel Blockers / therapeutic use Cardiomyopathy, Hypertrophic / drug therapy physiopathology Cardiovascular Agents / therapeutic use Clinical Trials as Topic Drug Evaluation, Preclinical Drug Repositioning Humans Myosins / antagonists & inhibitors Sodium Channel Blockers / therapeutic use Spironolactone / therapeutic use Vasodilator Agents / therapeutic use
来 源:
DOI:10.3390/ijms22137218
PDF(Sci-hub)
PDF(Pubmed)